A72-32115-45053 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-22
Dose 1 — Pfizer-BioNTech
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-10-06
Registered in v-safe
2021-10-11
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-04-12
Survey response — 12 months, dose 2
MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Preeclampsia (not resolved by delivery)

MedDRA releases: 2024-11 · check-in free text available
2022-04-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-04-21
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-22	Pfizer-BioNTech	No
2	2021-04-12	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-04-12

Symptoms: Preeclampsia (not resolved by delivery)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pre-eclampsia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release